Selected research
Market Structure
Global Amikacin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Amikacin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Amikacin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Amikacin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Amikacin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Amikacin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Amikacin include TNJ Chemical, Tuochukangyuan Pharm., 3B Scientific, Shenglide Biology, Bide Pharm., TargetMol, Pure Chemistry Scientific, OChem and MuseChem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Amikacin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Amikacin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Amikacin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amikacin market size, projected growth trends, production technologies, key applications, and end-use industries.
Amikacin Segment by Company
TNJ Chemical
Tuochukangyuan Pharm.
3B Scientific
Shenglide Biology
Bide Pharm.
TargetMol
Pure Chemistry Scientific
OChem
MuseChem
Mucule
Inter Bio Screen
Clearsynth
Biosynth
Angene
Amikacin Segment by Type
98% Purity Type
99% Purity Type
99.8% Purity Type
Others
Amikacin Segment by Application
Amikacin Eye Drops
Amikacin Injection
Others
Amikacin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amikacin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amikacin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amikacin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Amikacin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amikacin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Amikacin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Amikacin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 98% Purity Type
- 99% Purity Type
- 99.8% Purity Type
- Others
Applications
- Amikacin Eye Drops
- Amikacin Injection
- Others
Companies covered
- TNJ Chemical
- Tuochukangyuan Pharm.
- 3B Scientific
- Shenglide Biology
- Bide Pharm.
- TargetMol
- Pure Chemistry Scientific
- OChem
- MuseChem
- Mucule
- Inter Bio Screen
- Clearsynth
- Biosynth
- Angene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Amikacin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Amikacin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Amikacin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Amikacin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Amikacin Market Dynamics
- 2.1 Amikacin Industry Trends
- 2.2 Amikacin Industry Drivers
- 2.3 Amikacin Industry Opportunities and Challenges
- 2.4 Amikacin Industry Restraints
3 Amikacin Market by Manufacturers
- 3.1 Global Amikacin Revenue by Manufacturers (2021-2026)
- 3.2 Global Amikacin Sales by Manufacturers (2021-2026)
- 3.3 Global Amikacin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Amikacin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Amikacin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Amikacin Manufacturers, Product Type & Application
- 3.7 Global Amikacin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Amikacin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Amikacin Players Market Share by Revenue in 2025
- 3.8.3 2025 Amikacin Tier 1, Tier 2, and Tier 3
4 Amikacin Market by Type
- 4.1 Amikacin Type Introduction
- 4.1.1 98% Purity Type
- 4.1.2 99% Purity Type
- 4.1.3 99.8% Purity Type
- 4.1.4 Others
- 4.2 Global Amikacin Sales by Type
- 4.2.1 Global Amikacin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Amikacin Sales by Type (2021-2032)
- 4.2.3 Global Amikacin Sales Market Share by Type (2021-2032)
- 4.3 Global Amikacin Revenue by Type
- 4.3.1 Global Amikacin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Amikacin Revenue by Type (2021-2032)
- 4.3.3 Global Amikacin Revenue Market Share by Type (2021-2032)
5 Amikacin Market by Application
- 5.1 Amikacin Application Introduction
- 5.1.1 Amikacin Eye Drops
- 5.1.2 Amikacin Injection
- 5.1.3 Others
- 5.2 Global Amikacin Sales by Application
- 5.2.1 Global Amikacin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Amikacin Sales by Application (2021-2032)
- 5.2.3 Global Amikacin Sales Market Share by Application (2021-2032)
- 5.3 Global Amikacin Revenue by Application
- 5.3.1 Global Amikacin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Amikacin Revenue by Application (2021-2032)
- 5.3.3 Global Amikacin Revenue Market Share by Application (2021-2032)
6 Global Amikacin Sales by Region
- 6.1 Global Amikacin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Amikacin Sales by Region (2021-2032)
- 6.2.1 Global Amikacin Sales by Region (2021-2026)
- 6.2.2 Global Amikacin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Amikacin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Amikacin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Amikacin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Amikacin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Amikacin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Amikacin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Amikacin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Amikacin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Amikacin Revenue by Region
- 7.1 Global Amikacin Revenue by Region
- 7.1.1 Global Amikacin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Amikacin Revenue by Region (2021-2026)
- 7.1.3 Global Amikacin Revenue by Region (2027-2032)
- 7.1.4 Global Amikacin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Amikacin Revenue (2021-2032)
- 7.2.2 North America Amikacin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Amikacin Revenue (2021-2032)
- 7.3.2 Europe Amikacin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Amikacin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Amikacin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Amikacin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Amikacin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 TNJ Chemical
- 8.1.1 TNJ Chemical Company Information
- 8.1.2 TNJ Chemical Business Overview
- 8.1.3 TNJ Chemical Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 TNJ Chemical Amikacin Product Portfolio
- 8.1.5 TNJ Chemical Recent Developments
- 8.2 Tuochukangyuan Pharm.
- 8.2.1 Tuochukangyuan Pharm. Company Information
- 8.2.2 Tuochukangyuan Pharm. Business Overview
- 8.2.3 Tuochukangyuan Pharm. Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Tuochukangyuan Pharm. Amikacin Product Portfolio
- 8.2.5 Tuochukangyuan Pharm. Recent Developments
- 8.3 3B Scientific
- 8.3.1 3B Scientific Company Information
- 8.3.2 3B Scientific Business Overview
- 8.3.3 3B Scientific Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 3B Scientific Amikacin Product Portfolio
- 8.3.5 3B Scientific Recent Developments
- 8.4 Shenglide Biology
- 8.4.1 Shenglide Biology Company Information
- 8.4.2 Shenglide Biology Business Overview
- 8.4.3 Shenglide Biology Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Shenglide Biology Amikacin Product Portfolio
- 8.4.5 Shenglide Biology Recent Developments
- 8.5 Bide Pharm.
- 8.5.1 Bide Pharm. Company Information
- 8.5.2 Bide Pharm. Business Overview
- 8.5.3 Bide Pharm. Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Bide Pharm. Amikacin Product Portfolio
- 8.5.5 Bide Pharm. Recent Developments
- 8.6 TargetMol
- 8.6.1 TargetMol Company Information
- 8.6.2 TargetMol Business Overview
- 8.6.3 TargetMol Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 TargetMol Amikacin Product Portfolio
- 8.6.5 TargetMol Recent Developments
- 8.7 Pure Chemistry Scientific
- 8.7.1 Pure Chemistry Scientific Company Information
- 8.7.2 Pure Chemistry Scientific Business Overview
- 8.7.3 Pure Chemistry Scientific Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Pure Chemistry Scientific Amikacin Product Portfolio
- 8.7.5 Pure Chemistry Scientific Recent Developments
- 8.8 OChem
- 8.8.1 OChem Company Information
- 8.8.2 OChem Business Overview
- 8.8.3 OChem Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 OChem Amikacin Product Portfolio
- 8.8.5 OChem Recent Developments
- 8.9 MuseChem
- 8.9.1 MuseChem Company Information
- 8.9.2 MuseChem Business Overview
- 8.9.3 MuseChem Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 MuseChem Amikacin Product Portfolio
- 8.9.5 MuseChem Recent Developments
- 8.10 Mucule
- 8.10.1 Mucule Company Information
- 8.10.2 Mucule Business Overview
- 8.10.3 Mucule Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Mucule Amikacin Product Portfolio
- 8.10.5 Mucule Recent Developments
- 8.11 Inter Bio Screen
- 8.11.1 Inter Bio Screen Company Information
- 8.11.2 Inter Bio Screen Business Overview
- 8.11.3 Inter Bio Screen Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Inter Bio Screen Amikacin Product Portfolio
- 8.11.5 Inter Bio Screen Recent Developments
- 8.12 Clearsynth
- 8.12.1 Clearsynth Company Information
- 8.12.2 Clearsynth Business Overview
- 8.12.3 Clearsynth Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Clearsynth Amikacin Product Portfolio
- 8.12.5 Clearsynth Recent Developments
- 8.13 Biosynth
- 8.13.1 Biosynth Company Information
- 8.13.2 Biosynth Business Overview
- 8.13.3 Biosynth Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Biosynth Amikacin Product Portfolio
- 8.13.5 Biosynth Recent Developments
- 8.14 Angene
- 8.14.1 Angene Company Information
- 8.14.2 Angene Business Overview
- 8.14.3 Angene Amikacin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Angene Amikacin Product Portfolio
- 8.14.5 Angene Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Amikacin Value Chain Analysis
- 9.1.1 Amikacin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Amikacin Production Mode & Process
- 9.2 Amikacin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Amikacin Distributors
- 9.2.3 Amikacin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst